Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(2 intermediate revisions by one other user not shown)
Line 16: Line 16:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
!
 
−
!
 
−
!
 
−
!
 
−
!
 
 
|-
 
|-
 
|CHAPTER 2 (SOFT TISSUE TUMOURS)
 
|CHAPTER 2 (SOFT TISSUE TUMOURS)
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 54: Line 39:
 
|[[STBT5:Lipoma|Lipoma]]
 
|[[STBT5:Lipoma|Lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 70: Line 50:
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 86: Line 61:
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 102: Line 72:
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 126: Line 91:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 139: Line 102:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 148: Line 114:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
+
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 158: Line 124:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Hibernoma|Hibernoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 171: Line 135:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 180: Line 147:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Hibernoma|Hibernoma]]
+
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 190: Line 157:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 195: Line 165:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 208: Line 178:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 219: Line 190:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 228: Line 202:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
+
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 238: Line 212:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 251: Line 223:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 260: Line 235:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
+
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 245:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Elastofibroma|Elastofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 283: Line 256:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 292: Line 268:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
+
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 
|Disease
 
|Disease
 
|
 
|
Line 302: Line 278:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 315: Line 289:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 324: Line 301:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
+
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 
|Disease
 
|Disease
 
|
 
|
Line 334: Line 311:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 347: Line 322:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 356: Line 334:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Elastofibroma|Elastofibroma]]
+
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 366: Line 344:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 379: Line 355:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 388: Line 367:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
+
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 398: Line 377:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 411: Line 388:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 420: Line 400:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
+
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 430: Line 410:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 435: Line 418:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 448: Line 431:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 459: Line 443:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 468: Line 455:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
+
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 475: Line 462:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 484: Line 477:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
+
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 +
|Shashi Shetty and Reba Daniel (resident)
 +
|2/21/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Template added 2/21/2024
−
|
+
|-
 +
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 500: Line 499:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
+
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 510: Line 509:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 523: Line 520:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 532: Line 532:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
+
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 542: Line 542:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 555: Line 553:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 564: Line 565:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
+
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 574: Line 575:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 587: Line 586:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 596: Line 598:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
+
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 606: Line 608:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 619: Line 619:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 628: Line 631:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
+
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 638: Line 641:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 651: Line 652:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 660: Line 664:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
+
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 670: Line 674:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 683: Line 685:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 692: Line 697:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 
|Disease
 
|Disease
−
|Shashi Shetty and Reba Daniel (resident)
 
−
|2/21/2024
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|Template added 2/21/2024
 
 
|
 
|
 
|
 
|
Line 708: Line 708:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 718: Line 718:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 731: Line 729:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 740: Line 741:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
+
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 750: Line 751:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 763: Line 762:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 772: Line 774:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
+
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 782: Line 784:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 795: Line 795:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 804: Line 807:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
+
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 814: Line 817:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 819: Line 825:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Leiomyoma|Leiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 832: Line 838:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 843: Line 850:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 852: Line 862:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
+
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 862: Line 872:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 875: Line 883:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 884: Line 895:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
+
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 894: Line 905:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 907: Line 916:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 916: Line 928:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
+
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 926: Line 938:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 939: Line 949:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 948: Line 961:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
+
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 958: Line 971:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 971: Line 982:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 980: Line 994:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
+
|[[STBT5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 990: Line 1,004:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,003: Line 1,015:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,012: Line 1,027:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
+
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,022: Line 1,037:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,035: Line 1,048:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,044: Line 1,060:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
+
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,054: Line 1,070:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,059: Line 1,078:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,072: Line 1,091:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,083: Line 1,103:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,092: Line 1,115:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,102: Line 1,125:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,115: Line 1,136:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,124: Line 1,148:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
+
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,134: Line 1,158:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,139: Line 1,166:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,153: Line 1,180:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Glomus_tumour|Glomus tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,163: Line 1,190:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,172: Line 1,203:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
+
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 
|Disease
 
|Disease
 +
|James Solomon, MD, PhD
 +
|2/20/2022
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Alanna Church
 
|
 
|
 
|
 
|
−
|
+
|-
 +
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,188: Line 1,225:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
+
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,195: Line 1,232:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,204: Line 1,247:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyoma|Leiomyoma]]
+
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,214: Line 1,257:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,227: Line 1,268:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,236: Line 1,280:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
+
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,246: Line 1,290:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:PEComa|PEComa]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,259: Line 1,301:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,268: Line 1,313:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
+
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,278: Line 1,323:
 
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|Sadeem Qdaisat
 +
|10/1/23
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Working with Eric McGinnis
 
|
 
|
 +
|2021 template added
 
|-
 
|-
−
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
+
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,310: Line 1,365:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|Ganesh Pandurang, MD
 +
|2/28/24
 
|
 
|
 +
|PENDING
 
|
 
|
−
|
+
|Katherine Geiersbach
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
+
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,326: Line 1,387:
 
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 4 (BONE TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,348: Line 1,419:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
+
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,358: Line 1,429:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,371: Line 1,440:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Enchondroma|Enchondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,380: Line 1,452:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
+
|[[STBT5:Osteochondroma|Osteochondroma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,396: Line 1,463:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
+
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,406: Line 1,473:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Schwannoma|Schwannoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,419: Line 1,484:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,428: Line 1,496:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Neurofibroma|Neurofibroma]]
+
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,438: Line 1,506:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Perineurioma|Perineurioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,451: Line 1,517:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,460: Line 1,529:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
+
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,476: Line 1,540:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
+
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,486: Line 1,550:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,499: Line 1,561:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,508: Line 1,573:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
+
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,518: Line 1,583:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,531: Line 1,594:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteoma|Osteoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,540: Line 1,606:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
+
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,556: Line 1,617:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
+
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,566: Line 1,627:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,579: Line 1,638:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,588: Line 1,650:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
+
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,598: Line 1,660:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,611: Line 1,671:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,620: Line 1,683:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
+
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,636: Line 1,694:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
+
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,646: Line 1,704:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,659: Line 1,715:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,668: Line 1,727:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
+
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,678: Line 1,737:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,691: Line 1,748:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,700: Line 1,760:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
+
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,716: Line 1,771:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
+
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,726: Line 1,781:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,739: Line 1,792:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,748: Line 1,804:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
+
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
|Disease
 
|Disease
−
|James Solomon, MD, PhD
 
−
|2/20/2022
 
 
|
 
|
−
|PENDING
 
−
|
 
−
|Alanna Church
 
 
|
 
|
 
|
 
|
Line 1,764: Line 1,815:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
+
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,774: Line 1,825:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,787: Line 1,836:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,796: Line 1,848:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
+
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,806: Line 1,858:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,819: Line 1,869:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,828: Line 1,881:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
+
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,838: Line 1,891:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,851: Line 1,902:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,860: Line 1,914:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
+
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,876: Line 1,925:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:PEComa|PEComa]]
+
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,886: Line 1,935:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Bone_metastases|Bone metastases]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,899: Line 1,946:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,908: Line 1,958:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
+
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,918: Line 1,968:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 +
|Disease
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
 
|
 
|
 
|
 
|
Line 1,931: Line 1,979:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,940: Line 1,991:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
+
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
|Disease
 
|Disease
−
|Sadeem Qdaisat
 
−
|10/1/23
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Working with Eric McGinnis
 
 
|
 
|
−
|2021 template added
 
 
|
 
|
 
|
 
|
Line 1,956: Line 2,002:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
+
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
+
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Enchondroma|Enchondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondroma|Osteochondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoma|Osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bone_metastases|Bone metastases]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,918: Line 2,035:
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,934: Line 2,046:
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,950: Line 2,057:
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,966: Line 2,068:
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,982: Line 2,079:
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,998: Line 2,090:
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|

Latest revision as of 17:56, 28 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease
Elastofibroma Disease
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Solitary fibrous tumour Disease Shashi Shetty and Reba Daniel (resident) 2/21/2024 PENDING Katherine Geiersbach Template added 2/21/2024
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease
Infantile fibrosarcoma Disease
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Giant cell tumour of soft tissue Disease
Synovial haemangioma Disease
Intramuscular angioma Disease
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease
Haemosiderotic fibrolipomatous tumour Disease
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Clear cell sarcoma of soft tissue Disease
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease
CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat 10/1/23 PENDING Working with Eric McGinnis 2021 template added
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease Ganesh Pandurang, MD 2/28/24 PENDING Katherine Geiersbach
Sarcoma with BCOR genetic alterations Disease
CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Osteosarcoma Disease
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease
Osteofibrous dysplasia Disease
Adamantinoma of long bones Disease
Simple bone cyst Disease
Fibrocartilaginous mesenchymoma Disease
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Langerhans cell histiocytosis Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://content.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=14310"